Wailan Alexander M, Sartor Anna L, Zowawi Hosam M, Perry John D, Paterson David L, Sidjabat Hanna E
The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia
Health Protection Branch, Department of Health, Queensland Government, Brisbane, Queensland, Australia.
Antimicrob Agents Chemother. 2015 Dec;59(12):7405-10. doi: 10.1128/AAC.01319-15. Epub 2015 Sep 21.
The carbapenem resistance determinant blaNDM-1 has been found in various Gram-negative bacteria and upon different plasmid replicon types (Inc). Here, we present four patients within two hospitals in Pakistan harboring between two and four NDM-1-producing Gram-negative bacilli of different species coresident in their stool samples. We characterize the blaNDM-1 genetic contexts of these 11 NDM-1-producing Gram-negative bacilli in addition to other antimicrobial resistance mechanisms, plasmid replicon profiles, and sequence types (STs) in order to understand the underlying acquisition mechanisms of carbapenem resistance within these bacteria. Two common plasmid types (IncN2 and IncA/C) were identified to carry blaNDM-1 among the six different bacterial species isolated from the four patients. Two of these strains were novel Citrobacter freundii ST 20 and ST 21. The same IncN2-type blaNDM-1 genetic context was found in all four patients and within four different species. The IncA/C-type blaNDM-1 genetic context was found in two different species and in two of the four patients. Combining genetic context characterization with other molecular epidemiology methods, we were able to establish the molecular epidemiological links between genetically unrelated bacterial species by linking their acquisition of an IncN2 or IncA/C plasmid carrying blaNDM-1 for carbapenem resistance. By combining plasmid characterization and in-depth genetic context assessment, this analysis highlights the importance of plasmids in antimicrobial resistance. It also provides a novel approach for investigating the underlying mechanisms of blaNDM-1-related spread between bacterial species and genera via plasmids.
碳青霉烯耐药决定因子blaNDM-1已在多种革兰氏阴性菌以及不同的质粒复制子类型(Inc)中被发现。在此,我们报告了巴基斯坦两家医院的4名患者,其粪便样本中共存着2至4种产NDM-1的不同革兰氏阴性杆菌。我们对这11株产NDM-1的革兰氏阴性杆菌的blaNDM-1基因背景以及其他抗菌耐药机制、质粒复制子图谱和序列类型(STs)进行了表征,以了解这些细菌中碳青霉烯耐药性的潜在获得机制。在从4名患者分离出的6种不同细菌中,鉴定出两种常见质粒类型(IncN2和IncA/C)携带blaNDM-1。其中两株是新型弗氏柠檬酸杆菌ST 20和ST 21。在所有4名患者以及4种不同菌种中均发现了相同的IncN2型blaNDM-1基因背景。IncA/C型blaNDM-1基因背景存在于两种不同菌种以及4名患者中的两名患者体内。通过将基因背景表征与其他分子流行病学方法相结合,我们能够通过将携带blaNDM-1的IncN2或IncA/C质粒的获得与碳青霉烯耐药性联系起来,从而建立基因不相关细菌菌种之间的分子流行病学联系。通过结合质粒表征和深入的基因背景评估,该分析突出了质粒在抗菌耐药性中的重要性。它还为研究blaNDM-1相关的细菌菌种和属之间通过质粒传播的潜在机制提供了一种新方法。